Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Fourth Quarter And Year Ended September 30, 2013

Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that it plans to report its fiscal fourth quarter and September 30 year end financial results before the U.S. markets open on November 25, 2013. Enanta management will host a conference call at 8:30 a.m. ET to discuss these results.

Help employers find you! Check out all the jobs and post your resume.